Ingrid Hedenfalk
71 – 80 of 93
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer.
(
- Contribution to journal › Scientific review
-
Mark
Microarrays in breast cancer research and clinical practice - the future lies ahead
(
- Contribution to journal › Scientific review
-
Mark
cDNA Microarrays in Cancer Research.
2006) p.13-25(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Gene Expression Profiling Can Distinguish Tumor Subclasses of Breast Carcinomas.
2006) p.132-132(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2005
-
Mark
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.
(
- Contribution to journal › Article
-
Mark
Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
(
- Contribution to journal › Article
-
Mark
Microarray-based Analyses of Hypoxia-induced Transcriptional Changes in Breast Cancer Cell Lines
(
- Contribution to journal › Article
- 2003
-
Mark
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier
(
- Contribution to journal › Article
-
Mark
Molecular classification of familial non-BRCA1/BRCA2 breast cancer
(
- Contribution to journal › Article
- 2002
-
Mark
Gene expression profiling of hereditary and sporadic ovarian cancers reveals unique BRCA1 and BRCA2 signatures
(
- Contribution to journal › Article